Fisher Asset Management

Fisher Asset Management Portfolio holdings

AUM $252B
 

Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.

This Quarter Return
-0.5%
1 Year Return
+19.67%
3 Year Return
+104.4%
5 Year Return
+153.45%
10 Year Return
+356.28%
AUM
$91.1B
AUM Growth
+$91.1B
Cap. Flow
+$2.69B
Cap. Flow %
2.95%
Top 10 Hldgs %
26.31%
Holding
980
New
78
Increased
346
Reduced
342
Closed
77
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
COST icon
26
Costco
COST
$418B
$874M 0.96% 3,035,174 +96,610 +3% +$27.8M
FRLG
27
DELISTED
Large Cap Growth Index-Linked Exchange Traded Notes due 2028
FRLG
$862M 0.95% 7,167,344 -545,355 -7% -$65.6M
RDS.A
28
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$858M 0.94% 14,572,455 +716,424 +5% +$42.2M
SNY icon
29
Sanofi
SNY
$121B
$805M 0.88% 17,377,003 +508,580 +3% +$23.6M
NVO icon
30
Novo Nordisk
NVO
$251B
$786M 0.86% 15,211,300 +310,066 +2% +$16M
MRK icon
31
Merck
MRK
$210B
$757M 0.83% 8,996,510 +234,582 +3% +$19.7M
AZN icon
32
AstraZeneca
AZN
$248B
$725M 0.8% 16,261,961 +357,670 +2% +$15.9M
NVS icon
33
Novartis
NVS
$245B
$723M 0.79% 8,314,984 +247,749 +3% +$21.5M
JPM icon
34
JPMorgan Chase
JPM
$829B
$702M 0.77% 5,965,183 +153,852 +3% +$18.1M
MBB icon
35
iShares MBS ETF
MBB
$41B
$698M 0.77% 6,449,149 +401,451 +7% +$43.5M
SI
36
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$680M 0.75% 12,704,128 +1,192,541 +10% +$63.9M
CAT icon
37
Caterpillar
CAT
$196B
$679M 0.75% 5,376,797 +5,313,853 +8,442% +$671M
BUD icon
38
AB InBev
BUD
$122B
$670M 0.74% 7,041,510 +179,100 +3% +$17M
GSK icon
39
GSK
GSK
$79.9B
$652M 0.72% 15,267,588 +1,412,368 +10% +$60.3M
ASML icon
40
ASML
ASML
$292B
$649M 0.71% 2,612,581 +58,153 +2% +$14.4M
RTX icon
41
RTX Corp
RTX
$212B
$645M 0.71% 4,727,841 +117,400 +3% +$16M
PG icon
42
Procter & Gamble
PG
$368B
$627M 0.69% 5,039,515 -74,151 -1% -$9.22M
CVX icon
43
Chevron
CVX
$324B
$612M 0.67% 5,163,054 +123,800 +2% +$14.7M
SPSB icon
44
SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$8.42B
$608M 0.67% 19,703,786 +18,174,376 +1,188% +$561M
HSBC icon
45
HSBC
HSBC
$224B
$608M 0.67% 15,876,496 -438,644 -3% -$16.8M
UBS icon
46
UBS Group
UBS
$128B
$594M 0.65% 52,490,995 +1,384,055 +3% +$15.7M
NFLX icon
47
Netflix
NFLX
$513B
$593M 0.65% 2,216,329 +1,302,678 +143% +$349M
RIO icon
48
Rio Tinto
RIO
$102B
$567M 0.62% 10,894,565 +327,457 +3% +$17.1M
PBR icon
49
Petrobras
PBR
$79.9B
$562M 0.62% 38,822,835 -1,093,031 -3% -$15.8M
ING icon
50
ING
ING
$70.3B
$514M 0.56% 49,194,733 +13,109,071 +36% +$137M